Searched for
REGENERON PHARMACEUTICALS INC
Zydus launches biosimilar for ophthalmic careZydus Lifesciences has introduced Anyra, its first indigenously developed biosimilar for the treatment of visual impairment in India. This ...- Biocon Biologics secures market entry for Yesafili in USBiocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili...
- Biocon Biologics settles patent issue; paves way for launch of biosimilar product in CanadaBiocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...
- These are the stocks to watch as Covid enters its next phaseThe first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the...
- Cathie Wood's ARK funds rally on surge in growth stocksThe ARK Innovation fund, which is managed by firm founder Wood, gained 3.5 per cent on Monday and is now up 4.3 per cent for the year to da...
- AstraZeneca says antibody treatment failed in preventing COVID-19 in exposed patientsThe company said the participants in the trial were unvaccinated adults older than 18 years with confirmed exposure to a person with the co...
- Dow ends at record high after upbeat jobless claims reportLifted by Apple Inc, the S&P 500 rose after a Labor Department report showed initial claims for state unemployment benefits totaled a seaso...
- Pfizer begins early-stage study of oral drug to combat coronavirusThe drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate s...
- Eli Lilly and Co to supply 650,000 more doses of COVID-19 drug to U.S. governmentThe new purchase is part of a U.S. government deal to secure nearly 1 million doses of Lilly's bamlanivimab, a treatment similar to Regener...
- US allows emergency use of first COVID-19 antibody drugThe Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data showi...
- 2nd study testing a COVID-19 antibody drug has a setbackTests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is...
- Eli Lilly antibody drug fails in a COVID-19 study; others go onIndependent monitors had paused enrolment in the study two weeks ago because of a possible safety issue. But on Monday, the National Instit...
- Gilead questions WHO study that cast doubts on drug's COVID-19 benefitsIn a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its "Solidarity" trial had concluded t...
- Donald Trump 'no longer considered a transmission risk' for Covid: White House doctor"I am happy to report that in addition to the President meeting CDC criteria for the safe discontinuation of isolation, this morning's COVI...
- Wall Street gains as Trump to leave hospital, investors hope for stimulusAfter data last week showed an unexpected slowdown in the domestic manufacturing sector in September, figures on Monday showed activity in ...
- Lilly says antibody drug cuts COVID-19 hospitalization, may seek emergency use nodOf the total 302 patients treated with the Lilly drug, five or 1.7%, had to be hospitalized or required an emergency room visit. That compa...
- Next best thing to vaccine: Companies testing antibody drugs to treat, prevent Covid-19Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by trickin...
- Dow Jones gains on surprise services data, China-led rebound hopesThe Dow Jones Industrial Average was up 322.73 points, or 1.25 per cent, at 26,150.09.v
- What are antibody therapies and who is developing them for COVID-19?More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in lar...
- Scientists create antibody that claims to defeat coronavirus in labMore research is needed to see whether the findings are confirmed in a clinical setting and how precisely the antibody defeats the virus.
Load More
